241 related articles for article (PubMed ID: 27521366)
1. Preliminary Evaluation of the Effect of Investigational Ebola Virus Disease Treatments on Viral Genome Sequences.
Whitmer SL; Albariño C; Shepard SS; Dudas G; Sheth M; Brown SC; Cannon D; Erickson BR; Gibbons A; Schuh A; Sealy T; Ervin E; Frace M; Uyeki TM; Nichol ST; Ströher U
J Infect Dis; 2016 Oct; 214(suppl 3):S333-S341. PubMed ID: 27521366
[TBL] [Abstract][Full Text] [Related]
2. Review: Insights on Current FDA-Approved Monoclonal Antibodies Against Ebola Virus Infection.
Tshiani Mbaya O; Mukumbayi P; Mulangu S
Front Immunol; 2021; 12():721328. PubMed ID: 34526994
[TBL] [Abstract][Full Text] [Related]
3. Advances in Designing and Developing Vaccines, Drugs, and Therapies to Counter Ebola Virus.
Dhama K; Karthik K; Khandia R; Chakraborty S; Munjal A; Latheef SK; Kumar D; Ramakrishnan MA; Malik YS; Singh R; Malik SVS; Singh RK; Chaicumpa W
Front Immunol; 2018; 9():1803. PubMed ID: 30147687
[TBL] [Abstract][Full Text] [Related]
4. Progression of Ebola Therapeutics During the 2014-2015 Outbreak.
Mendoza EJ; Qiu X; Kobinger GP
Trends Mol Med; 2016 Feb; 22(2):164-173. PubMed ID: 26774636
[TBL] [Abstract][Full Text] [Related]
5. Development of therapeutics for treatment of Ebola virus infection.
Li H; Ying T; Yu F; Lu L; Jiang S
Microbes Infect; 2015 Feb; 17(2):109-17. PubMed ID: 25498866
[TBL] [Abstract][Full Text] [Related]
6. Assessing Antiviral Countermeasures Using Mouse Models of Ebolavirus Infection.
Kroeker A; Griffin BD; Qiu X; Kobinger G
Methods Mol Biol; 2017; 1628():273-282. PubMed ID: 28573628
[TBL] [Abstract][Full Text] [Related]
7. Clinical features and viral kinetics in a rapidly cured patient with Ebola virus disease: a case report.
Schibler M; Vetter P; Cherpillod P; Petty TJ; Cordey S; Vieille G; Yerly S; Siegrist CA; Samii K; Dayer JA; Docquier M; Zdobnov EM; Simpson AJH; Rees PSC; Sarria FB; Gasche Y; Chappuis F; Iten A; Pittet D; Pugin J; Kaiser L
Lancet Infect Dis; 2015 Sep; 15(9):1034-1040. PubMed ID: 26201298
[TBL] [Abstract][Full Text] [Related]
8. Treatment of ebola virus disease.
Kilgore PE; Grabenstein JD; Salim AM; Rybak M
Pharmacotherapy; 2015 Jan; 35(1):43-53. PubMed ID: 25630412
[TBL] [Abstract][Full Text] [Related]
9. Experimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical Trial.
Dunning J; Sahr F; Rojek A; Gannon F; Carson G; Idriss B; Massaquoi T; Gandi R; Joseph S; Osman HK; Brooks TJ; Simpson AJ; Goodfellow I; Thorne L; Arias A; Merson L; Castle L; Howell-Jones R; Pardinaz-Solis R; Hope-Gill B; Ferri M; Grove J; Kowalski M; Stepniewska K; Lang T; Whitehead J; Olliaro P; Samai M; Horby PW;
PLoS Med; 2016 Apr; 13(4):e1001997. PubMed ID: 27093560
[TBL] [Abstract][Full Text] [Related]
10. Anti-Ebola therapy for patients with Ebola virus disease: a systematic review.
Lee JS; Adhikari NKJ; Kwon HY; Teo K; Siemieniuk R; Lamontagne F; Chan A; Mishra S; Murthy S; Kiiza P; Hajek J; Bah EI; Lamah MC; Kao R; Fowler RA
BMC Infect Dis; 2019 May; 19(1):376. PubMed ID: 31046707
[TBL] [Abstract][Full Text] [Related]
11. Will There Be a Cure for Ebola?
Cardile AP; Warren TK; Martins KA; Reisler RB; Bavari S
Annu Rev Pharmacol Toxicol; 2017 Jan; 57():329-348. PubMed ID: 27959624
[TBL] [Abstract][Full Text] [Related]
12. Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.
Sissoko D; Laouenan C; Folkesson E; M'Lebing AB; Beavogui AH; Baize S; Camara AM; Maes P; Shepherd S; Danel C; Carazo S; Conde MN; Gala JL; Colin G; Savini H; Bore JA; Le Marcis F; Koundouno FR; Petitjean F; Lamah MC; Diederich S; Tounkara A; Poelart G; Berbain E; Dindart JM; Duraffour S; Lefevre A; Leno T; Peyrouset O; Irenge L; Bangoura N; Palich R; Hinzmann J; Kraus A; Barry TS; Berette S; Bongono A; Camara MS; Chanfreau Munoz V; Doumbouya L; Souley Harouna ; Kighoma PM; Koundouno FR; Réné Lolamou ; Loua CM; Massala V; Moumouni K; Provost C; Samake N; Sekou C; Soumah A; Arnould I; Komano MS; Gustin L; Berutto C; Camara D; Camara FS; Colpaert J; Delamou L; Jansson L; Kourouma E; Loua M; Malme K; Manfrin E; Maomou A; Milinouno A; Ombelet S; Sidiboun AY; Verreckt I; Yombouno P; Bocquin A; Carbonnelle C; Carmoi T; Frange P; Mely S; Nguyen VK; Pannetier D; Taburet AM; Treluyer JM; Kolie J; Moh R; Gonzalez MC; Kuisma E; Liedigk B; Ngabo D; Rudolf M; Thom R; Kerber R; Gabriel M; Di Caro A; Wölfel R; Badir J; Bentahir M; Deccache Y; Dumont C; Durant JF; El Bakkouri K; Gasasira Uwamahoro M; Smits B; Toufik N; Van Cauwenberghe S; Ezzedine K; D'Ortenzio E; Pizarro L; Etienne A; Guedj J; Fizet A; Barte de Sainte Fare E; Murgue B; Tran-Minh T; Rapp C; Piguet P; Poncin M; Draguez B; Allaford Duverger T; Barbe S; Baret G; Defourny I; Carroll M; Raoul H; Augier A; Eholie SP; Yazdanpanah Y; Levy-Marchal C; Antierrens A; Van Herp M; Günther S; de Lamballerie X; Keïta S; Mentre F; Anglaret X; Malvy D;
PLoS Med; 2016 Mar; 13(3):e1001967. PubMed ID: 26930627
[TBL] [Abstract][Full Text] [Related]
13. An RNA polymerase II-driven Ebola virus minigenome system as an advanced tool for antiviral drug screening.
Nelson EV; Pacheco JR; Hume AJ; Cressey TN; Deflubé LR; Ruedas JB; Connor JH; Ebihara H; Mühlberger E
Antiviral Res; 2017 Oct; 146():21-27. PubMed ID: 28807685
[TBL] [Abstract][Full Text] [Related]
14. [Recent Advances in Vaccines and Drugs Against the Ebola Virus].
Zhu X; Yao C; Wei Y; Kou Z; Hu K
Bing Du Xue Bao; 2015 May; 31(3):287-92. PubMed ID: 26470536
[TBL] [Abstract][Full Text] [Related]
15. Monitoring of Ebola Virus Makona Evolution through Establishment of Advanced Genomic Capability in Liberia.
Kugelman JR; Wiley MR; Mate S; Ladner JT; Beitzel B; Fakoli L; Taweh F; Prieto K; Diclaro JW; Minogue T; Schoepp RJ; Schaecher KE; Pettitt J; Bateman S; Fair J; Kuhn JH; Hensley L; Park DJ; Sabeti PC; Sanchez-Lockhart M; Bolay FK; Palacios G; ; ;
Emerg Infect Dis; 2015 Jul; 21(7):1135-43. PubMed ID: 26079255
[TBL] [Abstract][Full Text] [Related]
16. Ebola Virus Disease: Therapeutic and Potential Preventative Opportunities.
Fisher R; Borio L
Microbiol Spectr; 2016 Jun; 4(3):. PubMed ID: 27337455
[TBL] [Abstract][Full Text] [Related]
17. State-of-the-Art Workshops on Medical Countermeasures Potentially Available for Human Use Following Accidental Exposures to Ebola Virus.
Jahrling PB; Hensley LE; Barrett K; Lane HC; Davey RT
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S84-90. PubMed ID: 25957962
[TBL] [Abstract][Full Text] [Related]
18. [Current status of drug treatment against the disease caused by the Ebola virus].
Reina J
Rev Esp Quimioter; 2016 Feb; 29(1):1-7. PubMed ID: 26785224
[TBL] [Abstract][Full Text] [Related]
19. A review on the antagonist Ebola: A prophylactic approach.
Khan FN; Qazi S; Tanveer K; Raza K
Biomed Pharmacother; 2017 Dec; 96():1513-1526. PubMed ID: 29208326
[TBL] [Abstract][Full Text] [Related]
20. A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics.
Mulangu S; Dodd LE; Davey RT; Tshiani Mbaya O; Proschan M; Mukadi D; Lusakibanza Manzo M; Nzolo D; Tshomba Oloma A; Ibanda A; Ali R; Coulibaly S; Levine AC; Grais R; Diaz J; Lane HC; Muyembe-Tamfum JJ; ; Sivahera B; Camara M; Kojan R; Walker R; Dighero-Kemp B; Cao H; Mukumbayi P; Mbala-Kingebeni P; Ahuka S; Albert S; Bonnett T; Crozier I; Duvenhage M; Proffitt C; Teitelbaum M; Moench T; Aboulhab J; Barrett K; Cahill K; Cone K; Eckes R; Hensley L; Herpin B; Higgs E; Ledgerwood J; Pierson J; Smolskis M; Sow Y; Tierney J; Sivapalasingam S; Holman W; Gettinger N; Vallée D; Nordwall J;
N Engl J Med; 2019 Dec; 381(24):2293-2303. PubMed ID: 31774950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
